New incident report
Incident Report Number: 2022-0521
Registrant Reference Number: 2021-CA-000199
Registrant Name (Full Legal Name no abbreviations): The Hartz Mountain Corporation
Address: 400 Plaza Drive
City: Secaucus
Prov / State: New Jersey
Country: USA
Postal Code: 07094-3688
Domestic Animal
Country: CANADA
Prov / State: ONTARIO
PMRA Registration No. 29930 PMRA Submission No. EPA Registration No.
Product Name: Hartz UltraGuard OneSpot Flea and Tick Cat Drops Spot-on
Yes
Unknown
Site: Animal / Usage sur un animal domestique
Animal's Owner
Cat / Chat
Domestic Shorthair
1
Male
2
4.54
kg
Skin
>1 wk <=1 mo / > 1 sem < = 1 mois
>24 hrs <=3 days / >24 h <=3 jours
System
>3 days <=1 wk / >3 jours <=1 sem
No
No
Fully Recovered / Complètement rétabli
Treatment / Traitement
(eg. description of the frequency and severity of the symptoms
On 10-Jul-2021, a 2 year old, 4.54 kilogram, neutered, male, Domestic Shorthair cat, in unknown condition, with no known concomitant medical condition, was administered 1 tube of Hartz UltraGuard OneSpot Flea and Tick Cat Drops (S Methoprene) via the topical route by the animal owner. The product was used as a prevention and it was a first time use. On 12-Jul-2021, the cat developed a rash and hair loss at the application site. The affected area was approximately the size of a Canadian dollar. The animal owner applied bacitracin/polymyxin B via the topical route to the affected skin daily until approximately 15-Jul-2021. On approximately 19-Jul-2021, the symptoms resolved and the cat recovered without medical intervention. Discussed bathing the cat for product removal, if desired. Continuing to monitor at home was recommended. On previous unknown dates, the cat was administered unspecified flea and tick prevention by the animal owner, without issue. The unspecified product was prescribed by a veterinarian. No further information was received.
Minor
The information contained in this report is based on self-reported statements provided to the registrant during telephone interview(s). These self-reported descriptions of an incident have not been independently verified to be factually correct or complete descriptions of the incident. For that reason, information contained in this report does not and cannot form the basis for a determination of whether the reported clinical effects are causally related to exposure to the product identified in the telephone interviews.